+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Overactive Bladder Treatment Market Report 2026 - Product Thumbnail Image

Overactive Bladder Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
From
Ovulation Inducing Drugs Market Report 2026 - Product Thumbnail Image

Ovulation Inducing Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • May 2026
  • 308 Pages
  • Global
From
From
Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2026 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator